Next Article in Journal
1,2-Dihydroxyxanthone: Effect on A375-C5 Melanoma Cell Growth Associated with Interference with THP-1 Human Macrophage Activity
Previous Article in Journal
Voltammetric Evaluation of Diclofenac Tablets Samples through Carbon Black-Based Electrodes
Previous Article in Special Issue
Strategies for the Development of Glycomimetic Drug Candidates
Article Menu

Export Article

Open AccessReview

Developments in Carbohydrate-Based Cancer Therapeutics

Department of Chemistry and Biochemistry, University of Toledo, Toledo, OH 43606, USA
Author to whom correspondence should be addressed.
Pharmaceuticals 2019, 12(2), 84;
Received: 3 May 2019 / Revised: 24 May 2019 / Accepted: 29 May 2019 / Published: 4 June 2019
(This article belongs to the Special Issue Carbohydrates 2018)
PDF [1899 KB, uploaded 4 June 2019]


Cancer cells of diverse origins express extracellular tumor-specific carbohydrate antigens (TACAs) because of aberrant glycosylation. Overexpressed TACAs on the surface of tumor cells are considered biomarkers for cancer detection and have always been prioritized for the development of novel carbohydrate-based anti-cancer vaccines. In recent years, progress has been made in developing synthetic, carbohydrate-based antitumor vaccines to improve immune responses associated with targeting these specific antigens. Tumor cells also exhaust more energy for proliferation than normal cells, by consuming excessive amounts of glucose via overexpressed sugar binding or transporting receptors located in the cellular membrane. Furthermore, inspired by the Warburg effect, glycoconjugation strategies of anticancer drugs have gained considerable attention from the scientific community. This review highlights a small cohort of recent efforts which have been made in carbohydrate-based cancer treatments, including vaccine design and the development of glycoconjugate prodrugs, glycosidase inhibiting iminosugars, and early cancer diagnosis. View Full-Text
Keywords: cancer treatment; carbohydrate antigens; carbohydrate-based antitumor vaccines; warburg effect; iminosugar; cancer diagnosis cancer treatment; carbohydrate antigens; carbohydrate-based antitumor vaccines; warburg effect; iminosugar; cancer diagnosis

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Hossain, F.; Andreana, P.R. Developments in Carbohydrate-Based Cancer Therapeutics. Pharmaceuticals 2019, 12, 84.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top